Free Trial

Humanigen (HGEN) Competitors

$0.0002
0.00 (0.00%)
(As of 05/20/2024 ET)

HGEN vs. NOVNQ, VRAYQ, AHPI, STAB, UTRS, GNCA, HTGMQ, SCPS, IGNY, and KLDO

Should you be buying Humanigen stock or one of its competitors? The main competitors of Humanigen include NVN Liquidation (NOVNQ), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Statera Biopharma (STAB), Minerva Surgical (UTRS), Genocea Biosciences (GNCA), HTG Molecular Diagnostics (HTGMQ), Scopus BioPharma (SCPS), Ignyte Acquisition (IGNY), and Kaleido Biosciences (KLDO). These companies are all part of the "medical" sector.

Humanigen vs.

NVN Liquidation (NASDAQ:NOVNQ) and Humanigen (NASDAQ:HGEN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, community ranking, earnings, valuation and risk.

NVN Liquidation has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500. Comparatively, Humanigen has a beta of -1.04, indicating that its stock price is 204% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NVN Liquidation
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Humanigen
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Company Net Margins Return on Equity Return on Assets
NVN LiquidationN/A N/A N/A
Humanigen N/A N/A N/A

4.6% of Humanigen shares are held by institutional investors. 1.3% of NVN Liquidation shares are held by insiders. Comparatively, 21.7% of Humanigen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Humanigen received 23 more outperform votes than NVN Liquidation when rated by MarketBeat users.

CompanyUnderperformOutperform
NVN LiquidationN/AN/A
HumanigenOutperform Votes
23
57.50%
Underperform Votes
17
42.50%

In the previous week, Humanigen's average media sentiment score of 0.00 equaled NVN Liquidation'saverage media sentiment score.

Company Overall Sentiment
NVN Liquidation Neutral
Humanigen Neutral

NVN Liquidation has higher revenue and earnings than Humanigen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NVN Liquidation$23.68M0.00-$31.31M-$1.32N/A
Humanigen$1.70M0.01-$70.73MN/AN/A

Summary

NVN Liquidation and Humanigen tied by winning 3 of the 6 factors compared between the two stocks.

Get Humanigen News Delivered to You Automatically

Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

HGEN vs. The Competition

MetricHumanigenBiotechnology IndustryMedical SectorNASDAQ Exchange
Market Cap$24,000.00$209.07M$5.03B$8.00B
Dividend YieldN/A3.48%45.13%3.91%
P/E RatioN/A110.10124.9815.90
Price / Sales0.0114,890.832,535.6779.91
Price / CashN/A11.4632.7729.27
Price / Book0.006.975.014.45
Net Income-$70.73M-$24.77M$103.85M$213.12M
7 Day PerformanceN/A0.77%0.16%0.74%
1 Month PerformanceN/A6.05%4.83%6.06%
1 Year PerformanceN/A7.88%7.66%9.88%

Humanigen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOVNQ
NVN Liquidation
0 of 5 stars
N/AN/AN/A$22,000.00$23.68M0.0090Gap Up
VRAYQ
ViewRay
0 of 5 stars
N/AN/AN/A$20,000.00$102.21M0.00295
AHPI
Allied Healthcare Products
0 of 5 stars
N/AN/AN/A$16,000.00$27.05M0.00189News Coverage
STAB
Statera Biopharma
0 of 5 stars
$0.00
flat
N/A-96.5%$38,000.00$1.49M0.0046Negative News
UTRS
Minerva Surgical
0 of 5 stars
$0.00
flat
N/AN/A$9,000.00$50.29M0.00174
GNCA
Genocea Biosciences
0 of 5 stars
N/AN/AN/A$6,000.00$1.91M0.0074Analyst Forecast
HTGMQ
HTG Molecular Diagnostics
0 of 5 stars
$0.00
flat
N/AN/A$6,000.00$6.37M0.0053Gap Up
SCPS
Scopus BioPharma
0 of 5 stars
$0.00
flat
N/A-96.6%$46,000.00N/A0.0013
IGNY
Ignyte Acquisition
0 of 5 stars
$0.01
flat
N/A-98.9%$63,000.00N/A0.00N/A
KLDO
Kaleido Biosciences
0 of 5 stars
N/AN/AN/A$4,000.00$1.10M0.0076

Related Companies and Tools

This page (NASDAQ:HGEN) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners